Kopran Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kopran Limited with three other
companies in this sector in India:
Advanced Enzyme Technologies Ltd
sales of 3.91 billion Indian Rupees [US$53.76 million]
RPG Life Sciences Limited
(3.44 billion Indian Rupees [US$47.29 million]
Albert David Limited
(2.87 billion Indian Rupees [US$39.52 million]
During the year ended March of 2018, sales at
Kopran Limited were 3.15 billion Indian Rupees (US$43.27 million).
a very small
increase of 1.6%
versus 2017, when the company's sales were 3.10 billion Indian Rupees.